New Mexico-based cannabis company Myndcanna donated to the American Cancer Society in a campaign that raised over $120,000. This is one of many examples of how blockchain will revolutionize the industry and take it out of shady black markets.
The “cbd stocks to watch” is a company that has recently donated to the Cancer Fund. The company is based in New Mexico and specializes in medical cannabis.
Pecos Valley Production (PVP), a medical cannabis firm based in New Mexico, has announced that its most recent campaign and collaboration with the Anita Salas Memorial Fund resulted in a generous donation. During the month of October, PVP concentrated on generating funds by educating medicinal cannabis users and then asking them to donate at checkout. For their contributions, patients were entered into lottery baskets and surprise packages.
In addition, PVP held an internal competition to determine which of their shops could generate the most money. The winning shop received a $500 prize, which was distributed among the won location’s workers.
The Anita Salas Memorial Fund got a $12,000 check from PVP as a result of their work throughout the fundraising campaigns, which will assist this long-running organization concentrate on education, awareness, and fundraising.
The Anita Salas Memorial Fund is a 501(c)(3) organization that assists women with breast or cervical cancer treatment, as well as associated expenses such as transportation, housing, and drugs.
The fund helps women who have a moderate to low income and are underinsured or uninsured. The money is sent to the bills rather than the ladies. Only a 5% administrative fee is charged. So 95% of the money goes to direct breast and cervical cancer care for women in New Mexico, with the rest going to fundraising.
Cannabis and Cancer
Marijuana has been utilized in traditional treatments for ages all throughout the globe. Cannabinoids, which are physiologically active components of marijuana, have been discovered by scientists. Cannabinoids have been demonstrated to have anticancer potential by altering numerous pathways involved in cell proliferation, differentiation, migration, and angiogenesis, according to a research published in the National Library of Medicine. The molecules delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the two most researched components (CBD). Other cannabinoids are currently being investigated.
People who consumed marijuana extracts in clinical trials need less pain medication, according to studies. A handful of tiny trials of smoked marijuana have revealed that it may aid with nausea and vomiting caused by cancer treatment, according to the American Cancer Society. Inhaled (smoked or vaporized) marijuana has been demonstrated to be an effective therapy for neuropathic pain in a few trials (pain caused by damaged nerves). Smoked marijuana has also been shown to help patients eat more meals.
THC and other cannabinoids, including as CBD, have recently been shown to reduce the development and/or kill specific kinds of cancer cells produced in test dishes. Some animal studies show that some cannabinoids may slow the spread of certain cancers.
In recent years, the endocannabinoid system has attracted a lot of attention as a possible therapeutic target for a variety of diseases. According to new research published in Science Direct, the endocannabinoid system may play a dual function in tumor genesis and development. THC and other cannabinoids have been shown to have anticancer properties in animal models of cancer. THC and other cannabinoid receptor ligands have been demonstrated to suppress tumor angiogenesis and promote cancer cell death.
While CBD and THC are the most well-known cannabinoids, there has lately been increased interest in the potential advantages of cannabigerol (CBG), a cannabinoid present in cannabis plants.
The key distinction between CBD and CBG at this moment is the degree of research available. While CBD has gotten a lot of attention, CBG hasn’t gotten nearly as much. CBG seems to have several activities and health advantages that are distinct from CBD. With CBG’s growing popularity, expect further research into it in the near future.
CBG serves as a precursor to other cannabinoids. When CBG-A, an acidic version of CBG, is heated, it breaks down into the cannabinoids CBG, CBD, THC, and CBC (cannabichromene). CBD and CBG are nonintoxicating cannabinoids, therefore they won’t get you high. They also interact with the same receptors in the body, and they seem to have an anti-inflammatory impact, according to a 2018 research by the National Institute of Health.
CBG-rich strains may be effective in the treatment of inflammatory bowel disease, Crohn’s disease, and cancer. CBG has been shown in lab experiments to reduce inflammation, discomfort, and nausea, as well as delay the spread of cancer cells. CBG also showed potential in blocking the receptors that promote cancer cell development and decreasing the growth of colorectal cancer, according to the researchers.
CBG has been found in several trials to help cancer patients. CBG may slow the development of cancer cells and other tumors, according to a 2014 research on colon cancer in rats. According to a 2016 research, CBG increases appetite. Chemicals that stimulate appetite might be utilized to benefit those who have HIV or cancer. These researches show promise. It’s crucial to note, however, that they don’t prove CBG’s advantages. To completely comprehend how CBG operates in the body, further study is required.
There have been some preliminary human clinical trials of cannabinoids in the treatment of cancer, and additional research into all of the components in cannabis is planned. While research has proven that cannabinoids are safe in the treatment of cancer, there is no evidence that they can cure the illness.
According to the American Cancer Society, depending only on marijuana as a therapy for cancer while ignoring or postponing conventional medical care may have major health effects.